Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Palisade Bio, Inc. (PALI) had Stock-Based Compensation of $0.07M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.23M |
|
-- |
|
-- |
|
$2.31M |
|
$-2.31M |
|
$0.08M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.31M |
|
$-2.31M |
|
4.80M |
|
4.80M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$7.89M |
|
$0.00M |
|
$0.30M |
|
$8.19M |
|
$2.78M |
|
-- |
|
$0.08M |
|
$2.86M |
|
$5.33M |
|
$5.33M |
|
$5.33M |
|
4.40M |
|
| Cash Flow Statement Financials | |
$-2.33M |
|
-- |
|
$-0.26M |
|
$9.85M |
|
$7.26M |
|
$-2.59M |
|
|
Stock-Based Compensation |
$0.07M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.85% |
|
-41.83% |
|
-27.23% |
|
-41.83% |
|
$1.21 |
|
$-0.49 |
|
$-0.49 |
|